Treating adult cancer pain in primary care

Journal of the American Board of Family Practice

Volumn 17, Issue SUPPL. 1, 2004, Pages

  Rainone, Francine ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CAFFEINE; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; DEXAMPHETAMINE; DIPHENHYDRAMINE; FENTANYL; GABAPENTIN; GLUCOCORTICOID; HYDROCORTISONE; MECLOZINE; METHYLPHENIDATE; METOCLOPRAMIDE; MODAFINIL; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; OPIATE; PAMIDRONIC ACID; PARACETAMOL; PROCHLORPERAZINE; SCOPOLAMINE; SEROTONIN 3 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SPASMOLYTIC AGENT; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZOLEDRONIC ACID;

ADD ON THERAPY; ANALGESIA; ANTICHOLINERGIC EFFECT; BODY WEIGHT DISORDER; BONE METASTASIS; BONE PAIN; CANCER HORMONE THERAPY; CANCER PAIN; CANCER PATIENT; CLINICAL PRACTICE; CLINICAL PROTOCOL; COLIC; COMPETENCE; CONSTIPATION; CONSULTATION; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG ANTAGONISM; DRUG DOSE REDUCTION; DRUG POTENTIATION; DRUG SUBSTITUTION; EXTERNAL BEAM RADIOTHERAPY; FACE PAIN; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GENERAL PRACTITIONER; HEADACHE; HUMAN; MEDICAL ASSESSMENT; NAUSEA; NERVE BLOCK; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; PATIENT ADVOCACY; PATIENT EDUCATION; PHYSICAL ACTIVITY; PREVALENCE; PRIMARY MEDICAL CARE; PRURITUS; REVIEW; SEDATION; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; URTICARIA; VISCERAL PAIN; VOMITING; WEIGHT GAIN; YOGA; ADULT; ARTICLE; BONE; EMERGENCY HEALTH SERVICE; METABOLISM; NEOPLASM; PAIN; PAIN ASSESSMENT; PAIN CLINIC; PRACTICE GUIDELINE; PRIMARY HEALTH CARE;

ADULT; BONE AND BONES; EMERGENCY MEDICAL SERVICES; FACIAL PAIN; HEADACHE; HUMANS; NEOPLASMS; PAIN; PAIN CLINICS; PAIN MEASUREMENT; PRACTICE GUIDELINES; PRIMARY HEALTH CARE;

EID: 21644476355     PISSN: 08938652     EISSN: 15448770     Source Type: Journal    
DOI: 10.3122/jabfm.17.suppl_1.s48     Document Type: Review

References (48)

1. Portenoy RK. Contemporary diagnosis and management of pain in oncologic and AIDS patients, 3rd ed. Newtown (PA): Handbooks in Health Care; 2000. p. 7-9.
2. Grond S, Zech D, Diefenbach C, Bischoff A. Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage 1994;9:772-8.
3. Zech DFJ, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization guidelines for cancer pain relief: a 10 year prospective study. Pain 1995;63:65-76.
4. Cleeland CS, Gonin R, Hatfield AK, et al. The prevalence of pain in outpatients with metastatic cancer. N Engl J Med 1994;330:592-6.
5. Merskey H. Classification of chronic pain: description of chronic pain syndromes and definitions of pain terms. Pain 1979;(Suppl 3):S217.
6. Galer BS, Dworkin RH. A clinical guide to neuropathic pain. Minneapolis (MN): Healthcare Information Programs; 2000. p. 4-6.
7. Cancer pain relief and palliative care. Geneva, Switzerland: World Health Organization; 1996.
8. Kaye P. Notes on symptom control in hospice and palliative care. Essex (CT): Hospice Education Institute; 1998. p. 217.
9. Ashburn MA, Lipman AG, Carr D, Rubingh C. Principles of analgesia use in the treatment of acute pain and cancer pain, 5th ed. Glenview (IL): American Pain Society; 2003. p. 34-6.
10. Janjan NA. Radiotherapeutic management of spinal metastases. J Pain Symptom Manage 1996;11:47-56.
11. Tryciecky EW, Gottschalk A, Ludema K. Oncologic imaging: interactions of nuclear medicine with CT and MRI using the bone scan as a model. Semin Nucl Med 1997;27:142-51.
12. Arcangeli G, Micheli A, Arcangeli G, et al. The responsiveness of bone metastases to radiotherapy: the effect of site, histology and radiation dose on pain relief. Radiother Oncol 1989;14:95-101.
13. Bates T, Yarnold JR, Blitzer P, et al. Bone metastasis consensus statement. Int J Radiat Oncol Biol Phys 1992;23:215-6.
14. Hoskin PJ. Radiotherapy in the management of bone pain. Clin Orthop 1995;(312):105-19.
15. Pereira J. Management of bone pain. In: Portenoy RK, Bruera E, editors. Topics in palliative care. Vol. 3. Cambridge (UK): Oxford University Press; 1998. p. 79-116.
16. Hong D, Byers MR, Oswald RJ. Dexamethasone treatment reduces sensory neuropeptides and nerve sprouting reactions in injured teeth. Pain 1993;55:171-81.
17. Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991;111:735-40.
18. Giammarile F, Mognetti T, Resche I. Bone pain palliation with strontium-89 in cancer patients with bone metastases. Q J Nucl Med 2001;45:78-83.
19. Ross JR, Saunders Y, Edmonds PM, Patel S, Broadley KE, Johnston SR. Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer [published erratum appears in BMJ 2004;328:384]. BMJ 2003;327:469.
20. Berenson JR, Hillner BE, Kyle RA, et al. American society of clinical oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol 2002;20:3719-36.
21. Ali SM, Esteva FJ, Hortobagyi G, et al. Safety and efficacy of bisphosphonates beyond 24 months in cancer patients. J Clin Oncol 2001;19:3434-7.
22. Hillner BE, Ingle JN, Berenson JR, et al. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. J Clin Oncol 2000;18:1378-91.
23. Lipton A, Theriault RL, Hortobagyi GN, et al. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials. Cancer 2000;88:1082-90.
24. Deys RA, Diehl AK. Cancer as a cause of back pain: frequency, clinical presentation and diagnostic strategies. Gen Intern Med 1988;3:230-8.
25. Maranzano E, Latini P. Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. Int J Radiat Oncol Biol Phys 1995;15;32:959-67.
26. Maranzano E, Latini P, Checcaglini F, et al. Radiation therapy of spinal cord compression caused by breast cancer: report of a prospective trial. Int J Radiat Oncol Biol Phys 1992;24:301-6.
27. Heimdal K, Hirschberg H, Slettebo H, et al. High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression. J Neurooncol 1992;12:141-4.
28. Maranzano E, Latini P, Checcaglini F, et al. Radiation therapy in metastatic spinal cord compression. A prospective analysis of 105 consecutive patients. Cancer 1991;67:1311-7.
29. Sorensen S, Helweg-Larsen S, Mouridsen H, Hansen HH. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. Eur J Cancer 1994;30A:22-7.
30. Loblaw DA, Laperriere NJ. Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline. J Clin Oncol 1998;16:1613-23.
31. Twycross R. The risks and benefits of corticosteroids in advanced cancer. Drug Saf 1994;11:163-78.
32. Vecht CJ, Haaxma-Reiche H, van Putten W, et al. Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression. Neurology 1989;39:1255-7.
33. Laval G, Girardier J, Lassauniere JM, et al. The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction? Palliat Med 2000;14:3-10.
34. McQuay H, Carrroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ 1995;311:1047-52.
35. Yajnik S, Singh GP, Singh G, Kumar M. Phenytoin as a coanalgesic in cancer pain. J Pain Symptom Manage 1992;7:209-13.
36. Swerdlow M. Anticonvulsant drugs and chronic pain. Clin Neuropharmacol 1984;7:51-82.
37. Rosenberg JM, Harrell C, Ristic H, Werner RA, de Rosayro AM. The effect of gabapentin on neuropathic pain. Clin J Pain 1997;13:251-5.
38. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants for neuropathic pain. Pain 1996;68:217-27.
39. Elja K, Tiina T, Pertti NJ. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain 1996;64:293-302.
40. Ventafridda V, Bonezzi C, Caraceni A, et al. Antidepressants for cancer pain and other painful syndromes with deafferentation component: comparison of amitriptyline and trazodone. Ital J Neurol Sci 1987;8:579-87.
41. Evidence report/technology assessment: number 7. Treatment of depression - newer pharmacotherapies. Rockville (MD): Agency for Health Care Policy and Research; 1999.
42. Hippisley-Cox J, Pringle M, Hammersley V, et al. Antidepressants as risk factor for ischemic heart disease: case-control study in primary care. BMJ 2001;323:666-9.
43. Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 2000;108:2-8.
44. Nelson JC, Mazure C, Bowers MD, et al. Synergistic effects of fluoxetine and desipramine: a prospective study. Presented at the 21st meeting of the Collegium International Neuro-psychopharmacologicum Congress; 1998 Jul 12-16; Glasgow, Scotland.
45. Weilburg JB, Rosenbaum JF, Biederman J, et al. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry 1989;50:447-9.
46. Marshall KA. Managing cancer pain: basic principles and invasive treatments. Mayo Clinic Proc 1996;71:472-7.
47. Miguel R. Interventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder? Cancer Control 2000;7:149-56.
48. Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg 1995;80:290-9.